Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anna Lembke
Use of Opioid Agonist Therapy for Medicare Patients in 2013
JAMA Psychiatry
Medicine
Psychiatry
Mental Health
The Mineralocorticoid Receptor Agonist, Fludrocortisone, Differentially Inhibits Pituitary–adrenal Activity in Humans With Psychotic Major Depression
Psychoneuroendocrinology
Mental Health
Endocrine
Endocrinology
Autonomic Systems
Psychiatry
Biological Psychiatry
Metabolism
Diabetes
Related publications
Medicare Formulary Coverage and Restrictions for Opioid Potentiators From 2013 to 2017
Journal of General Internal Medicine
Internal Medicine
Personal Viewpoint on Opioid Agonist Therapy and Transplantation
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Performance of the Centers for Medicare & Medicaid Services’ Opioid Overutilization Criteria for Classifying Opioid Use Disorder or Overdose
JAMA - Journal of the American Medical Association
Medicine
Declining Use Rates of Revascularization for Medicare Patients
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Better Agonist for the Opioid Receptors
Chemistry Central Journal
Chemistry
The Time for Emergency Department Opioid Agonist Therapy Is Now: “A BC Perspective”
Canadian Journal of Emergency Medicine
Emergency Medicine
Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment
Substance Abuse and Rehabilitation
Alcohol Screening Among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program
Journal of Psychoactive Drugs
Medicine
Psychology
Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries
JAMA network open
Medicine